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Abstract 
Background: Intravenous balanced anesthesia (IVA) is desirable during the evacuation of retained products of 
conception (ERPC) to avoid the use of inhalational anesthetics agents that may cause uterus relaxation, the 
possibility of bleeding, and the risk of uterus perforation. 
Objectives: The aim of this study was to compare the efficacy and safety of ketofol (a mixture of propofol and 
ketamine) versus fentafol (a mixture of propofol and fentanyl) during the ERPC. 
Methods: A double-blind, randomized comparative study was conducted among a total of 60 women of 
childbearing age categorized as grades I and II according to the American Society of Anesthesiologist (ASA), 
presented for ERPC. The patients were selected and randomized blindly into two groups (K group and F group), 
with 30 patients in each group. The K group was given ketofol (1ml containing 5mg of propofol and 5mg of 
ketamine) and F group was given fentafol (1ml containing 5mg propofol and 5mcg fentanyl). An intravenous 
loading dose of ketofol or fentafol was given slowly, with doses ranging from 1ml to 2ml/10kg, to reach level 5 or 
6 of the Ramsay Scale of Sedation (RSS), followed by small incremental doses which were given when RSS 
dropped to 4. Hemodynamic parameters, success, and side effects were assessed throughout the procedures. 
Results: K group demonstrated a significant increase in heart rate (HR) and blood pressure (BP), compared to 
significant decreases in the F group. Decreases in oxygen saturation (SpO2) and respiratory rate (RR) were 
observed more in the F group. However, no patients developed hypertension, hypotension, apnea, hypoxemia or 
serious adverse effects. Ketofol showed less propofol consumption and a short recovery time.  
Conclusions: Both ketofol and fentafol offer optimum conditions for ERPC. Ketofol is characterized by more 
stable hemodynamic parameters, a smaller dosage and faster recovery. [Ethiop.J. Health Dev. 2019; 33(2):88-93] 
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Background 
Evacuation of Retained Products of Conception is a 
common procedure among women of childbearing age 
worldwide. Most of the cases present with anxiety and 
other psychological disorders related to their loss of 
fetus and associated vaginal bleeding, especially with 
recurrent abortions. These factors may increase the 
pain associated with the procedure. Consequently, 
anesthesia plays a major role during ERPC. The choice 
of anesthesia will be affected by certain considerations, 
including availability, effectiveness, safety, side 
effects, practitioner’s choice, cost, and women’s 
preferences (1). It could be performed under local, 
regional, sedation/analgesia and general anesthesia 
(GA) (2,3). Due to the complications of GA, many 
practitioners try to avoid it. Sedation/analgesia may be 
a good choice, and many different combinations can be 
used. Ketofol and fentafol are simple, safe and low 
cost, and could be used effectively, especially in 
developing countries. Because ketofol and fentafol 
cause no issues with airway patency, there is little need 
for airway instrumentation. A small total dose of 
propofol and ketamine or fentanyl is utilized to achieve 
a satisfactory level of sedation/analgesia. This is 
accompanied by few adverse events and residual 
anesthetics, leading to early ambulation and discharge. 
Ketofol utilization for emergency department 
procedural sedation/analgesia is efficacious (4,5). Both  
propofol-ketamine and propofol-fentanyl combinations 
are found to be rapid, pleasant and safe during the 
induction and maintenance of total intravenous 
endotracheal intubation GA, with only a few 
unpleasant side effects and only minor hemodynamic 
effects (5). 
 
New applications have been developed to administer 
ketamine involving small doses, either alone or in 
combination with other anesthetic agents. Nowadays, it 
is used extensively in anesthesia, palliative care, 
intensive care, and procedural sedation for both adults 
and children (5,6). Propofol has antiemetic, anxiolytic 
and antipruritic effects. It is characterized by rapid 
induction and recovery, which makes its use preferable 
during day case surgery (7,8). Fentanyl, a lipid-soluble 
opioid, has a rapid onset and short duration of action, 
with potent properties. Fentanyl has been available for 
more than 50 years. Even with new potent, safer, and 
faster onset generations of the drug, it remains popular 
and is used extensively. It has a minimal cardiovascular 
effect and does not cause histamine release (9,10). In 
our study, we have aimed to compare the efficacy and 
safety of ketofol (a mixture of propofol and ketamine) 
with fentafol (a mixture of propofol and fentanyl) 
during the ERPC. The secondary objective was to 
assess and compare ketofol- and fentafol-related 
complications.  
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Material and methods 
This double-blind, randomized comparative study was 
conducted in Soba University, Ibrahim Malik, and 
Academic Charity Hospitals, Khartoum, Sudan from 
early June to late August 2016. Ethical approval was 
obtained from the ethical committee of Soba University 
Hospital, College of Medicine at Khartoum University. 
Permission was obtained from the authorities at each of 
the hospitals. A total of 60 patients of childbearing age 
who presented with incomplete abortion for ERPC 
were enrolled in the study, including those classified as 
ASA class I: healthy, non-smoking, no or minimal 
alcohol use; and ASA class II: mild diseases only 
without substantive functional limitations. Exclusion 
criteria included patients with hypertension, 
hypotension, hepatic or renal diseases, difficult 
airways, known hypersensitivity to propofol, ketamine 
or fentanyl, full stomach or need for rapid sequence 
intubation, mental illnesses and psychiatric conditions. 
Also, patients unwilling to participate were excluded 
from the study. 
 
All patients were informed, and written consent was 
obtained. Preoperative assessment and evaluation for 
every patient were done as per normal procedures. 
Investigations and a fasting regimen were followed as 
routine. Patients were randomly assigned to one of two 
groups, K or F group, 30 patients in each, using a 
computer-generated block randomization program. The 
results of the selection process were kept in an opaque 
envelope and an assigned person allocated each patient 
accordingly to one of the groups. K group received the 
ketofol, a mixture of propofol and ketamine via a 20ml 
syringe, in a 1:1 ratio (1ml containing 5mg propofol 
and 5mg ketamine), while F group was given fentafol, 
a mixture of propofol and fentanyl in a 20ml syringe, 
with 1ml containing 5mg propofol and 5mcg fentanyl. 
These were prepared by an anesthesia technician and 
were concealed from both the assigned anesthetist and 
the one who administered them. There were no visible 
differences in appearance between the two mixtures. 
All patients were pre-medicated with ondansetron 4mg 
and glycopyrrolate 0.2mg intravenously. 
 
In the operation room, patients were connected to 
standard equipment to monitor heart rate, 
electrocardiograph (ECG), SpO2, respiratory rate, and 
noninvasive blood pressure before the drugs were 
administered. Monitoring was continued throughout 
the procedure and in the post-anesthesia care unit 
(PACU). An intravenous cannula was secured, and 
ringer lactate fluid was started. Supplemental oxygen 
via nasal cannula with a flow rate of 4L/minute was 
given to all patients. All resuscitation drugs and 
equipment were ready. Drugs were administered by the 
anesthetist in charge, with a person assisting and 
another one for monitoring of the patients. Ketofol or 
fentafol were given slowly with doses ranging from 1 
to 2 ml/10 kg until an optimum level of sedation was 
reached. The operation started at 5 or 6 levels as per 
RSS (Table 1). Incremental doses depended on clinical 
signs and RSS, and were given when RSS dropped to 
4. Recordings of the cardiorespiratory parameters were 
made every 5 to 15 minutes. Needs for airway 
management and rescue analgesia were recorded. All 
patients were given 10 units of syntocinon infusion in 
500ml normal saline near the end of the procedure. 
During the procedure and postoperatively, 
complications such as nausea, vomiting, shivering, 
hallucination, delirium and bad emergence phenomena 
were recorded. The end of monitoring and discharge of 
the patient from PACU followed a return to the 
baseline level of consciousness, protective reflexes, 
and when SpO2 was greater than 92% on room air. 
 
Data entry and analysis using the Statistical Package 
for Social Sciences (SPSS version 21.0) was 
performed. The categorical data are presented as 
numbers and percentages, and were subjected to Chi-
square test for analysis, while the parametric data are 
presented as mean and standard deviation and were 
subjected to ANOVA test. The statistical significance 
was considered at P-value ≤ 0.05. 
 
Table 1: Ramsay sedation scale 
Score Response 
1 Anxious or restless or both 
2 Cooperative, orientated and tranquil 
3 Responding to commands 
4 Brisk response to stimulus 
5 Sluggish response to stimulus 
6 No response to stimulus 
 
Results 
Table 2 shows the demographic characteristics, while 
Table 3 shows the intraoperative effects of ketofol and 
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Table 2: The demographic characteristics of both groups 
 K group (n = 30) F group (n = 30) P-value 
Age 
Range 






































The mean duration of operation 23.40±5.69 25.07±6.30 0.286 
K = Ketofo; F = Fentafol 
Data was expressed as a mean ± SD, numbers and percentages (ANOVA test). 
Table 3: The mean of the baseline and intraoperative parameters in both groups 
 
 K group 
(n = 30) 
F group 
(n = 30) 
P-value K group 
(n = 30) 
F group 
(n = 30) 
P-value 
Baseline  Intraoperative  
Systolic blood 
pressure 





75.53±6.43 75.73±7.24 0.910 82±6.37 69.53±7.15 <0.001 
Mean arterial blood 
pressure 
90.43±4.44 90.70±6.59 0.853 98.67±3.78 85.27±5.82 <0.001 
Heart rate 79.33±8.29 78.53±8.69 0.717 87.23±7.50 69.50±7.14 <0.001 
Oxygen saturation 97.17±0.95 97.50±0.73 0.137 96.47±1.01 95.40±1.04 <0.001 
Respiratory rate 15.67±1.15 15.43±1.10 0.412 12.57±1.30 12.17±1.21 0.222 
Data was expressed as a mean ± SD (ANOVA test). 
 
Patients in the K group had an increase in HR from the 
baseline (79.33±8.29 to 87.23±7.50), while the F group 
showed a decrease (from 78.53±8.69 to 69.5±7.14) 
(highly significant P-value). 
 
The systolic BP in K group increased from 
120.70±6.90 preoperatively to 132.27±3.96 
intraoperatively, while in F group it decreased from 
121.97±8.17 to 116.67±6.42 (highly significant P-
value). The diastolic BP increased in K group from the 
preoperative level of 75.53±6.43 to 82±6.37 
intraoperatively, while it dropped in F group 
(75.73±7.24 to 69.53±7.15) (P-value <0.001 in both). 
The mean arterial pressure (MAP) of K group 
increased from 90.43±4.44 to 98.67±3.78, while in F 
group it decreased from 90.70±6.59 to 85.27±5.82 
(highly significant P-value). 
 
Intraoperatively, SpO2 dropped from 97.17±0.95 to 
96.47±1.01 in K group. In F group, there was a greater 
drop, from 97.50±0.73 to 95.40±1.04 (highly 
significant P-value). 
 
The intraoperative difference in the RR between the 
two groups was found to be insignificant. However, 
there were decreases in intraoperative RR from the 
baseline in both groups. In K group, it decreased from 
15.67±1.15 to 12.57±1.30, while in F group it 
decreased from 15.43±1.10 to 12.17±1.21 (highly 
significant P-value in both). 
 
However, there are no clinical significances, as none of 
the patients developed hypertension, hypotension, 
apnea, or hypoxemia. Also, no patient developed 
vomiting or movement that could interfere with the 
operation. 
 
Table 4 shows the postoperative effects of ketofol and 












91     Ethiop. J. Health Dev 
 
Ethiop. J. Health Dev.2019;33(2) 
Table 4: The mean of postoperative parameters for both groups 
 
 K group (n = 30) F group (n = 30) P-value 
Systolic blood pressure 124.83±6.41 119.60±7.20 0.004 
Diastolic blood pressure 78.20±6.58 74.50±6.77 0.036 
Mean arterial blood pressure 93.73±4.27 89.53±5.61 0.002 
Heart rate 81.90±6.52 77.73±7.81 0.029 
Oxygen saturation 98.90±0.92 97.80±1.37 0.001 
Respiratory rate 13.97±0.96 13.50±1.14 0.089 
Data was expressed as a mean ± SD (ANOVA test). 
 
Postoperatively, systolic BP in K group decreased to 
124.83±6.41, while in F group it increased to 
119.60±7.20, with a significant P-value. The diastolic 
BP in the K group decreased to 78.20±6.58, while in F 
group it increased to 74.50±6.77. The difference is 
marginally significant (P-value 0.036). The MAP in the 
K group decreased to 93.73±4.27 and in the F group 
increased to 89.53±5.61 (P-value 0.002). 
 
The HR of group K and group F were 81.90±6.52 and 
77.73±7.81, respectively (significant P-value). The 
postoperative difference of SpO2 between the two 
groups was significant (98.90±0.92 in K group and 
97.80±1.37 in F group) (P-value 0.001). 
 
Table 5 shows the adverse events, needs for airway 
management, rescue analgesia, and sedative agents for 
both groups. 
 
Table 5: The adverse events, needs for airway management, rescue analgesia, and sedative agents for both 
groups 
 





























Need for airway alignment 





















Need for rescue analgesia 0 0   
Need for sedative agents 2 (6.57%) 0  0.156 
 Data is expressed as numbers and percentages. P < 0.05 is significant (Chi square test). 
 
There were no instances of hypoxemia, apnea, 
vomiting, delirium, or nightmares. One patient from F 
group experienced mild self-limiting nausea. Two 
patients from K group had a mild form of 
hallucination, which was treated effectively by small 
dose of intravenous midazolam (P-value 0.156). Head 
tilt or chin lift was needed in two patients in K group 
compared to three patients in F group (P-value 0.224). 
Airway instrumentation was not recorded. No rescue 
analgesia was needed in PACU. 
 
Table 6 shows the propofol consumption, procedure 
duration, sedation time, and time from last dose to full 
recovery. 
 
Table 6: Propofol consumption, procedure duration, sedation time, and time from last dose to full recovery 
  
 K group (n = 30) F group (n = 30) P-value 
Propofol consumption 100.67±19.86 112.50±21.76 0.032 
The mean duration of operation 23.40±5.69 25.07±6.30 0.286 
Sedation time 35.40±5.45 39.07±6.20 0.018 
Time from last dose to full recovery 14.10±2.55 16.90±2.73 <0.001 
Data was expressed as a mean ± SD (ANOVA test). 
 
There was no statistical difference in the mean duration 
of procedure between the two groups. Sedation time in 
K group was lower than F group (significant P-value 
0.018). 
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The mean of the total dose of propofol was higher in 
the F group compared with the K group, with 
significant difference (P-value 0.032). Time from the 
last dose to full recovery was higher in F group 




IVA is desirable during ERPC to avoid the use of 
inhalational anesthetic agents, which may cause 
relaxation of the uterus, resulting in more bleeding and 
the risk of uterus perforation during the procedure. 
Both ketofol and fentafol can provide an optimum 
sedation/analgesia for many minor surgical procedures, 
including ERPC. In each mixture, one drug will 
counteract the most severe disadvantages of the other. 
 
Kestin et al. evaluated anesthesia for ERPC among 44 
patients. They compared alfentanil plus etomidate and 
fentanyl plus thiopentone with 70% nitrous oxide in 
oxygen. They report a higher rate of return of higher 
mental function in the alfentanil-etomidate technique. 
However, it was associated with significantly more 
pain on injection and a higher frequency of 
postoperative vomiting (40%) (11). Jakobsson et al. 
studied four different combinations of IVA in patients 
who underwent termination of pregnancy under GA. 
The patients were randomly allocated to receive one of 
four anesthetic combinations; (1) propofol-ketamine 
20mg, (2) propofol-fentanyl 0.1mg, (3) thiopentone-
fentanyl 0.1mg, (4) methohexitone-fentanyl 0.1mg. All 
combinations offered good conditions to perform the 
procedure for termination of pregnancy. However, the 
propofol-fentanyl combination was found to be the best 
in regards to hemodynamic stability (12). 
 
Following intravenous administration of fentanyl, its 
analgesic effect will occur within one to two minutes. 
It is 100 to 200 times more potent than morphine. 
Despite the minimal cardiovascular effects of fentanyl 
and lack of plasma histamine release, a decrease in HR 
and BP may occur (10).  
 
Our study revealed good hemodynamic stability, with 
marginal superiority of ketofol. No patient in the 
ketofol group developed clinical tachycardia or 
hypertension. Fentafol was associated with more drops 
in HR and BP. However, these drops, clinically, were 
insignificant, as neither bradycardia nor hypotension 
occurred. This finding is similar to Bajwa et al., who 
found a slight decrease in HR (9%) with fentanyl-
propofol compared to an increase in the propofol-
ketamine group. Also, the BP fall in the fentanyl-
propofol compares with a slight increase in the 
propofol-ketamine group (5). In a study on ketofol in 
the ER for procedural sedation/analgesia, Willman et 
al. report only a few adverse events, which were either 
self-limiting or responded to minimal interventions 
(13). Also, another study of ketofol for painful minor 
operations shows stable hemodynamic parameters, 
with no clinical tachycardia or hypertension (14). 
 
In our study, most patients maintained their airway. No 
patient needed either basic or advanced airway support. 
No patient developed hypoxia or apnea. Some patients 
needed only airway alignment in the form of head tilt 
or chin lift, while jaw thrust was rarely used. The 
lowest SpO2 recorded was 94% in the F group. The 
greatest decrease in the RR was with fentafol. 
However, no RR less than 10/min was recorded. Bajwa 
et al. state no difference in SpO2 between ketofol and 
fentafol. This may be because the patients in that study 
were intubated. However, they recorded a better 
recovery ventilation score in the propofol-ketamine 
group (5). Willman et al. report transient hypoxia in 
three patients (2.6%) during ketofol procedural 
sedation/analgesia among a cohort of 140 patients. One 
patient (0.9%) required bag-valve mask ventilation. 
Four patients (8.7%) required repositioning for airway 
malalignment. No patient needed endotracheal 
intubation (13). Sharma et al. report more respiratory 
depression with fentafol. However, only simple 
maneuverings were required to solve the airway mal-
alignments (15). In another study, ketofol presented a 
few airway complications, which were resolved by the 
same simple technique (14). 
 
As propofol lacks analgesic properties, it cannot be 
used as a sole agent to provide anesthesia. The dose 
used alone to prevent patient movement may cause 
significant impairment of cardio-respiratory function. 
The adding of narcotic could decrease the required 
dose of propofol, but may result in cardio-respiratory 
depression (16). Kb et al. compared propofol and 
ketamine versus propofol and fentanyl for puerperal 
sterilization. They noticed more intraoperative 
respiratory depression, airway obstruction, and apnea 
with fentafol. Co-administration of low-dose ketamine 
is known to produce positive mood effects and enhance 
early recovery. While ketamine preserves airway 
patency, the addition of propofol may abolish the 
unwanted side effects of ketamine (16). Prakash et al. 
compared three different concentrations of propofol-
ketamine and propofol-fentanyl, in a sample of 60 adult 
females, scheduled for elective day care gynecological 
procedures. Patients had received a slow bolus 
injection followed by small aliquots of ketamine-
propofol (1:1) (group A), ketamine-propofol (1:2) 
(group B), and fentanyl-propofol (group C). No 
differences in hemodynamic stability were recorded 
(17). 
 
No patient, in our study developed postoperative 
vomiting, delirium, nightmares or headaches. However, 
one patient from F group experienced mild nausea, 
which was self-limiting. Two patients in the K group 
had a mild form of hallucination in the postoperative 
period, treated by a small dose of intravenous 
midazolam with immediate response. These may have 
been due to the small doses we used. Also, a high dose 
of ketamine may increase the occurrence of nausea and 
vomiting (16). In the study of ketofol by Willman and 
Andolfatto, three patients (2.6%) had mild unpleasant 
emergence, of whom one (0.9%) received midazolam 
(13). Perumal et al. support the effectiveness of 
midazolam premedication in attenuation of the 
postoperative emergence phenomenon related to 
ketamine anesthesia (18). 
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In this study, the mean of the total dose of propofol 
was higher in fentafol. Time from the last dose to full 
recovery was found to be shorter in the K group. The 
median recovery time reported by Willman and 
Andalfatto was 15 minutes (13). Sharma et al. 
demonstrate asmaller dose of propofol consumed in the 
ketofol (15). Different studies of propofol–ketamine or 
propofol–fentanyl show smooth recovery with minimal 
residual effects (5,13-15). During the whole stay in the 




Both ketofol and fentafol offer safe, effective and 
optimum sedation/analgesia for ERPC. Ketofol is 
characterized by more stable hemodynamic parameters, 
smaller dose and faster recovery time. For these 
reasons, ketofol showed superior advantage over 
fentafol and should be recommended during the ERPC 
sedation/analgesia procedure. Even with safety and the 
absence of serious adverse events, feasible and tight 
monitoring is still recommended. 
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